News & Updates

Using fish oil injectable lipid emulsions (ILE) in managing adults with cholestatic intestinal failure-associated liver disease (IFALD) seems effective and is safe, with no essential fatty acid (EFA) deficiencies observed up to 4 years of use, suggests a study.

A prospective cohort study has linked prenatal use of aspirin to better neurocognitive development in offspring.

In healthy individuals with functional constipation, probiotics supplementation does not appear to increase bowel movement frequency as compared with placebo, according to a study.

Deucravacitinib, an oral selective inhibitor of tyrosine kinase 2 (TYK2), shows promise in the treatment of lichen planopilaris (LPP), with substantial reductions in disease activity, according to the interim analysis of an open-label, single-arm trial.

Relative fat mass (RFM) accurately identifies people with an elevated body fat percentage (BF%), but it is not as accurate as dual energy x-ray absorptiometry (DXA) in estimating BF%, reports a Chile study.

Treatment with lithium aspartate yields no significant effect on long COVID symptoms of fatigue and cognitive dysfunction, as shown in a study.

Treatment with upadacitinib demonstrated superior efficacy in achieving near-complete skin clearance and little to no itch at 16 weeks compared with dupilumab among adolescents and adults with moderate-to-severe atopic dermatitis (AD), according to the LEVEL UP study presented at EADV 2024.

Smoking does not appear to carry an excess risk of the growth of intracranial aneurysms, according to the results of a meta-analysis.